Dolby Laboratories (DLB) reported $346.71 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 2.9%. EPS of $1.06 for the same period compares to $1.14 a year ago.
The reported revenue represents a surprise of +4.19% over the Zacks Consensus Estimate of $332.77 million. With the consensus EPS estimate being $0.90, the EPS surprise was +17.78%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Dolby Laboratories performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Dolby Laboratories here>>>
Shares of Dolby Laboratories have returned -4.7% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Oct-12 | |
| Oct-07 | |
| Sep-23 | |
| Sep-15 | |
| Sep-10 | |
| Aug-27 | |
| Aug-21 | |
| Aug-13 | |
| Aug-08 | |
| Aug-06 | |
| Jul-31 | |
| Jul-30 | |
| Jul-30 | |
| Jul-20 | |
| Jul-14 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite